Methocarbamol is a centrally-acting skeletal muscle relaxant with sedative properties used for acute musculoskeletal pain. It should be avoided in geriatric patients due to increased fall risk and is contraindicated in myasthenia gravis. The injectable form is contraindicated in renal impairment. Seizures have been reported, particularly with IV administration or in patients with epilepsy history. Not recommended during pregnancy or breastfeeding.
ميثوكاربامول molecular structure diagram from the DrugsPRO substance library.
Also known as: Robax, Robaxin
Classification
Chemical: Medicine
Psychoactive: Depressant
Tag: Carbamate
Tag: Muscle Relaxant
Tag: Sedative
Effects
Sedation
Muscle Relaxation
Motor Impairment
Physical Euphoria
Headache
Nausea
Dizziness
Drowsiness
Cognitive Impairment
Motor Control Loss
Anxiety Suppression
Dysphoria
Dulled Perception
Cognitive Dysphoria
Disinhibition
External Hallucination
Double Vision
Routes of Administration
Oral
Dosage
Threshold: 500 mg
Light: 500-750 mg
Common: 1000-1500 mg
Strong: 2000-3000 mg
Heavy: 3000 mg
Duration
Onset: 0.25-0.5 h
Comeup: 0.5-1 h
Peak: 1-2 h
Offset: 2-4 h
After Effects: 6-8 h
Intramuscular
Dosage
Common: 1000 mg
Duration
No data available for this section yet.
Intravenous
Dosage
Common: 1000 mg
Duration
No data available for this section yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Methocarbamol - دليل المواد DrugsPRO
Methocarbamol: Methocarbamol is a centrally-acting skeletal muscle relaxant with sedative properties used for acute musculoskeletal pain. It should be avoided in geriatric patients due to increased fall risk and is contraindicated in myasthenia gravis. The injectable form is contraindicated in renal
